News

Deal Announcements

BioAtla Bags $30 Million Development Funding

Monday, June 15, 2015 5:30:00 AM PDT | VentureDeal
   San Diego, California  --  Biotechnology company BioAtla has received $30 million in development investment.

BioAtla says that it aims to "solve critical protein development challenges and produce novel, IP-protectable products."

Investors in the financing were not disclosed.

BioAtla will use the proceeds to accelerate the development of its CAB antibody drug pipeline.

The company was founded by Chairman and CEO Jay Short, previously of SG Biofuels and Biotech Investment Group.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1